MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 106 filers reported holding MYOVANT SCIENCES LTD in Q3 2021. The put-call ratio across all filers is 3.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $854,982 | -99.9% | 31,713 | -2.3% | 0.00% | – |
| Q3 2022 | $582,676,000 | +44.5% | 32,443 | +0.0% | 0.00% | – |
| Q2 2022 | $403,254,000 | -6.7% | 32,442 | 0.0% | 0.00% | – |
| Q1 2022 | $432,127,000 | -14.5% | 32,442 | 0.0% | 0.00% | – |
| Q4 2021 | $505,122,000 | -30.6% | 32,442 | 0.0% | 0.00% | – |
| Q3 2021 | $727,999,000 | -1.4% | 32,442 | 0.0% | 0.00% | – |
| Q2 2021 | $738,705,000 | +21.1% | 32,442 | +9.5% | 0.00% | – |
| Q1 2021 | $609,785,000 | -44.5% | 29,630 | -25.5% | 0.00% | -100.0% |
| Q4 2020 | $1,099,083,000 | +121.3% | 39,793 | +12.6% | 0.00% | – |
| Q3 2020 | $496,611,000 | -50.8% | 35,346 | -27.8% | 0.00% | -100.0% |
| Q2 2020 | $1,009,328,000 | +417.3% | 48,949 | +89.4% | 0.00% | – |
| Q1 2020 | $195,115,000 | -57.7% | 25,843 | -13.0% | 0.00% | – |
| Q4 2019 | $460,789,000 | – | 29,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |